The fourth study by Montoya Perez et al. [22] aimed to develop and validate biparametric MRI radiomics and blood kallikrein (peptidase family of which prostate specific antigen (PSA) is a member) models for the detection of clinically significant PCa. This evidence concerns the gene LAP3 and posterior cortical atrophy.